Literature DB >> 23819464

Three-dimensional telomere dynamics in follicular thyroid cancer.

Landon Wark1, Adrian Danescu, Suchitra Natarajan, Xuguang Zhu, Sheue-yann Cheng, Sabine Hombach-Klonisch, Sabine Mai, Thomas Klonisch.   

Abstract

BACKGROUND: Over the last decade, annual incidence rates for thyroid cancer have been among the highest of all cancers in the Western world. However, the genomic mechanisms impacting thyroid carcinogenesis remain elusive.
METHODS: We employed an established mouse model of follicular thyroid cancer (FTC) with a homozygous proline to valine mutation (Thrb(PV/PV)) in the thyroid receptor β1 (TRβ1) and applied quantitative three-dimensional (3D) telomere analysis to determine 3D telomeric profiles in Thrb(PV)(/PV), Thrb(PV/)(+), and Thrb(+/+) mouse thyrocytes before and after histological presentation of FTC.
RESULTS: Using quantitative fluorescent in situ hybridization (Q-FISH) and TeloView™ image analysis, we found altered telomeric signatures specifically in mutant mouse thyrocytes. As early as 1 month of age, Thrb(PV/PV) mouse thyrocytes showed more telomeres than normal and heterozygous age-matched counterparts. Importantly, at the very early age of 1 month, 3D telomeric profiles of Thrb(PV/PV) thyrocyte nuclei reveal genetic heterogeneity with several nuclei populations exhibiting different telomere numbers, suggestive of various degrees of aneuploidy within the same animal. This was detected exclusively in Thrb(PV/PV) mice well before the presentation of histological signs of thyroid carcinoma.
CONCLUSIONS: We identified quantitative 3D telomere analysis as a novel tool for early detection and monitoring of thyrocyte chromosomal (in)stability. This technique has the potential to identify human patients at risk for developing thyroid carcinoma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23819464      PMCID: PMC3926167          DOI: 10.1089/thy.2013.0118

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  62 in total

1.  A Synthetic Medium for the Cultivation of C. diphtheriae.

Authors:  J H Mueller
Journal:  J Bacteriol       Date:  1938-11       Impact factor: 3.490

Review 2.  Formation of non-random extrachromosomal elements during development, differentiation and oncogenesis.

Authors:  Fabien Kuttler; Sabine Mai
Journal:  Semin Cancer Biol       Date:  2006-10-26       Impact factor: 15.707

3.  The Stability of Broken Ends of Chromosomes in Zea Mays.

Authors:  B McClintock
Journal:  Genetics       Date:  1941-03       Impact factor: 4.562

Review 4.  Alternative lengthening of telomeres: models, mechanisms and implications.

Authors:  Anthony J Cesare; Roger R Reddel
Journal:  Nat Rev Genet       Date:  2010-03-30       Impact factor: 53.242

5.  Telomere length in neoplastic and nonneoplastic tissues of patients with familial and sporadic papillary thyroid cancer.

Authors:  Marco Capezzone; Silvia Cantara; Stefania Marchisotta; Giulia Busonero; Caterina Formichi; Michele Benigni; Serena Capuano; Paolo Toti; Kalliopi Pazaitou-Panayiotou; Giuseppe Caruso; Anton Ferdinando Carli; Nazzareno Palummo; Furio Pacini
Journal:  J Clin Endocrinol Metab       Date:  2011-08-24       Impact factor: 5.958

6.  Image analysis of papillary thyroid carcinoma fine-needle aspirates: significant association between aneuploidy and death from disease.

Authors:  C D Sturgis; N P Caraway; D A Johnston; S I Sherman; L Kidd; R L Katz
Journal:  Cancer       Date:  1999-06-25       Impact factor: 6.860

7.  Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex.

Authors:  L S Kirschner; J A Carney; S D Pack; S E Taymans; C Giatzakis; Y S Cho; Y S Cho-Chung; C A Stratakis
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

8.  Telomeric aggregates and end-to-end chromosomal fusions require myc box II.

Authors:  A Caporali; L Wark; B J Vermolen; Y Garini; S Mai
Journal:  Oncogene       Date:  2006-09-04       Impact factor: 9.867

9.  Telomere-driven tetraploidization occurs in human cells undergoing crisis and promotes transformation of mouse cells.

Authors:  Teresa Davoli; Titia de Lange
Journal:  Cancer Cell       Date:  2012-06-12       Impact factor: 31.743

Review 10.  Telomere-driven genomic instability in cancer cells.

Authors:  Chantal Desmaze; Jean-Charles Soria; Marie-Anne Freulet-Marrière; Noelle Mathieu; Laure Sabatier
Journal:  Cancer Lett       Date:  2003-05-15       Impact factor: 8.679

View more
  3 in total

1.  Three-dimensional Nuclear Telomere Organization in Multiple Myeloma.

Authors:  Ludger Klewes; Rhea Vallente; Eric Dupas; Carolin Brand; Dietrich Grün; Amanda Guffei; Chirawadee Sathitruangsak; Julius A Awe; Alexandra Kuzyk; Daniel Lichtensztejn; Pille Tammur; Tiiu Ilus; Anu Tamm; Mari Punab; Morel Rubinger; Adebayo Olujohungbe; Sabine Mai
Journal:  Transl Oncol       Date:  2013-12-01       Impact factor: 4.243

2.  Genetic Heterogeneity of HER2 Amplification and Telomere Shortening in Papillary Thyroid Carcinoma.

Authors:  Paola Caria; Silvia Cantara; Daniela Virginia Frau; Furio Pacini; Roberta Vanni; Tinuccia Dettori
Journal:  Int J Mol Sci       Date:  2016-10-21       Impact factor: 5.923

3.  High Mobility Group A2 protects cancer cells against telomere dysfunction.

Authors:  Suchitra Natarajan; Farhana Begum; Jeonga Gim; Landon Wark; Dana Henderson; James R Davie; Sabine Hombach-Klonisch; Thomas Klonisch
Journal:  Oncotarget       Date:  2016-03-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.